文献速递骨质疏松与代谢性骨病

代谢相关脂肪性肝病与骨密度:2017-2018年美国国家健康与营养调查的横断面研究

Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017-2018.
PubMed 文献 · Osteoporos Int · 2023-01-31

该研究基于2017-2018年美国国家健康与营养调查(NHANES)中50岁及以上参与者,纳入817人(非MAFLD组436人,MAFLD组381人),采用多因素线性回归和多因素logistic回归分析MAFLD与骨密度及骨质疏松的关系。结果显示MAFLD人群股骨骨密度更高、骨质疏松风险未增加,但横断面设计无法确定因果关系。

要点

  • MAFLD组股骨骨密度高于非MAFLD组,尤其在≥50岁男性和≥65岁女性中。
  • 按BMI分层,肥胖男性(BMI ≥ 30 kg/m2)合并MAFLD者股骨骨密度高于对照组,女性无此趋势。
  • 多因素logistic回归显示MAFLD组骨质疏松风险未增加。

核心结论

  • 本研究发现MAFLD人群较非MAFLD人群骨密度更高、骨质疏松风险更低。
  • 因本研究为横断面研究,无法确定MAFLD与骨密度之间的因果关系,未来需进一步研究探讨MAFLD对骨代谢的影响。

研究设计与样本

  • 本研究为横断面研究,纳入2017-2018年美国国家健康与营养调查(NHANES)中年龄≥50岁的参与者。
  • 最终分析共纳入817名参与者,其中非MAFLD组436人,MAFLD组381人。
  • 采用多因素线性回归模型分析MAFLD与骨密度的关联,采用多因素logistic回归模型评估MAFLD与骨质疏松的关系。

主要发现

  • MAFLD组参与者股骨骨密度高于非MAFLD组,尤其在≥50岁男性和≥65岁女性中。
  • 按BMI分层的亚组分析显示,肥胖男性(BMI ≥ 30 kg/m2)合并MAFLD者股骨骨密度高于对照组,但女性中无此趋势。
  • 多因素logistic回归模型显示,MAFLD组参与者骨质疏松风险未增加。

关键数值与推荐

  • MAFLD定义基于2020年专家小组基于非酒精性脂肪性肝病提出的新定义。
  • 肥胖定义为BMI ≥ 30 kg/m2。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 本研究为横断面研究,无法确定MAFLD与骨密度之间的因果关系。
  • 未来需进一步研究探讨MAFLD对骨代谢的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: This research is a cross-sectional study based on the participants aged 50 years and older from National Health and Nutrition Examination Survey (NHANES) database. The metabolic associated fatty liver disease (MAFLD) population has higher BMD and a lower risk of osteoporosis than those without MAFLD. INTRODUCTION: MAFLD is a new definition presented by panel of experts based on non-alcoholic fatty liver disease in 2020. However, the link between MAFLD and bone mineral density (BMD) is uncertain. Thus, the present study aimed to investigate the relationship between MAFLD and BMD. METHODS: This cross-sectional study included subjects aged ≥ 50 years from the National Health and Nutrition Examination Survey 2017-2018. Multivariate linear regression models were performed to investigate the association between MAFLD and BMD. Moreover, the relationship between MAFLD and osteoporosis was assessed using multiple logistic regression models. RESULTS: Finally, 817 participants (non-MAFLD, n = 436; MAFLD, n = 381) were included in the final analysis. The results demonstrated that participants with MAFLD showed higher femoral BMDs than those without MAFLD, especially among males aged ≥ 50 years and females aged ≥ 65 years. Moreover, the results showed that obese men (BMI ≥ 30 kg/m2) with MAFLD had higher femoral BMDs than the control group according to subgroup analyses stratified by BMI, but this trend was not present in women. In addition, multiple logistic regression models showed that participants with MAFLD had no increased risks of osteoporosis. CONCLUSION: The present study found that the MAFLD population has higher BMD and a lower risk of osteoporosis than those without MAFLD. Because the present study was a cross-sectional study, we could not identify the cause-effect relation between MAFLD and BMD. Therefore, additional research needs to be performed to explore the influences of MAFLD on bone metabolism in the future.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Liu J, Tang Y, Feng Z, et al. Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017-2018. Osteoporos Int. 2023. PMID: 36719471. doi:10.1007/s00198-023-06687-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。